A team of Pillsbury lawyers represented Invitae Corporation in its private placement of $1.15 billion of convertible senior notes to support the company's future growth initiatives. The investment was led by SB Management, a subsidiary of SoftBank Group Corp.
Invitae is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time and lower prices.
Read more about the transaction here.
The Pillsbury team was led by Corporate partner Stan Wong and included partners Gabriella Lombardi and Mike Hird, counsel Julie Park and associates Jasmine Alves, Christopher Wing and Kendy Chan. Partner Harsha Reddy advised the team on Tax matters.